Skip to Main Content
Back to News

Insider Sale: VP of $ALKS Sells 3,743 Shares

Automated

Samuel Joseph Parisi, the VP of $ALKS, sold 3,743 shares of the company on 02-25-2025 for an estimated $131,978. We received data on the trade from a recent SEC filing. This was a sale of approximately 32.7% of their shares of this class of stock. Following this trade, they now own 7,717 shares of this class of $ALKS stock.

$ALKS Insider Trading Activity

$ALKS insiders have traded $ALKS stock on the open market 14 times in the past 6 months. Of those trades, 0 have been purchases and 14 have been sales.

Here’s a breakdown of recent trading of $ALKS stock by insiders over the last 6 months:

  • CRAIG C. HOPKINSON (EVP R&D, Chief Medical Officer) has made 0 purchases and 10 sales selling 604,446 shares for an estimated $19,860,519.
  • SAMUEL JOSEPH PARISI (VP, Finance (Interim PAO)) has made 0 purchases and 2 sales selling 5,070 shares for an estimated $179,338.
  • CHRISTIAN TODD NICHOLS (SVP, Chief Commercial Officer) sold 5,208 shares for an estimated $151,813
  • CATO T LAURENCIN sold 2,691 shares for an estimated $85,708

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$ALKS Hedge Fund Activity

We have seen 158 institutional investors add shares of $ALKS stock to their portfolio, and 206 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your Google News feed.Google News Logo

Suggested Articles